A feasible study for measurement of lipid mediator in exhaled breath condensate of the chronic cough patients and healthy subjects
Not Applicable
- Conditions
- Patients with chronic cough and healthy subjects
- Registration Number
- JPRN-UMIN000025716
- Lead Sponsor
- Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Not provided
Exclusion Criteria
Key exclusion criteria were: use of histamin H1 receptor antagonist, inhaled/oral/intravenous corticosteroid, leukotriene receptor antagonist, beta2-aganist, theophylline, macroraide, expectorant drug, and proton pump inhibitor; women of childbearing potential or of breast-feeding; mental disorder or psychiatric symptom; several medical conditions prohibiting partitipation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To investigate the feasibility for measurement of lipid mediator in exhaled breath condensate of the chronic cough patients and healthy subjects
- Secondary Outcome Measures
Name Time Method To compare the concentration of 5-HETE, 12-HETE, 15-HETE, PGD2, PGE2, PGI2, 6-keto PGF1alpha, LTB4, LTD4 and LTE4 in the exhaled breath condensate among the chronic cough patients and healthy subjects